Kevin M. Flanigan, MD, is the Robert F. and Edgar T. Wolfe Foundation Endowed Chair in Neuromuscular Research at Nationwide Children’s Hospital, and Professor of Pediatrics and Neurology at The Ohio State University College of Medicine. Certified by the American Board of Psychiatry and Neurology in both Neurology and Neuromuscular Medicine, Dr. Flanigan is Director of the Center for Gene Therapy in The Research Institute at Nationwide Children's and a leading expert in neuromuscular disorders. He also leads the world-class Neuromuscular Disorders program at Nationwide Children's, which provides coordinated care with pediatric experts from more than a dozen specialties.

Dr. Flanigan earned his medical degree from Rush Medical College and completed his internship at the University of Michigan Health System before completing his Neurology residency and fellowship in Neuromuscular Disorders at the Johns Hopkins Hospital, and an additional post-doctoral laboratory fellowship in Human Molecular Biology and Genetics at the University of Utah.

Nathalie Goemans is a pediatrician and child neurologist, with certification in rehabilitation medicine, affiliated to the KUL University of Leuven, currently emeritus since November 2020. She was a staff member since 1987 at the University Hospitals Leuven, Belgium, as head of clinic within the department of Pediatrics (Child Neurology) and head of the Neuromuscular Reference Centre for Children at the University Hospitals Leuven, and Assistant Professor at the Faculty of Medicine, University of Leuven, Belgium. She is consultant at DVC Heder, Antwerp, Belgium, a rehabilitation center with residential setting for neuromuscular patients.

Research activities involve translational and clinical research in various neuromuscular disorders, the development of new therapies for Duchenne muscular dystrophy and spinal muscular atrophies and the research and development of outcome measures to assess interventions in these diseases.

Dr. McDonald is an internationally recognized pediatric physical medicine & rehabilitation physician who is board-certified in neuromuscular medicine and pediatric rehabilitation medicine. He currently serves as Medical Director of the spina bifida program at Shriners Children's Northern California and is also Professor of Clinical Physical Medicine and Rehabilitation and Professor of Clinical Pediatrics at the University of California Davis School of Medicine. He is also Director of the NIDRR Rehabilitation Research and Training Center in Neuromuscular Disease at the University of California Davis School of Medicine.

Dr. McDonald’s research has focused on the development of novel therapeutics for neuromuscular diseases, and his work has contributed to the development of precision-based therapeutics for Duchenne muscular dystrophy and the first two approved therapies targeting the dystrophin gene abnormalities that cause Duchenne muscular dystrophy. Dr. McDonald's professional affiliations include the Muscular Dystrophy Association, the American Academy of Physical Medicine and Rehabilitation, the American Academy of Cerebral Palsy and Developmental Medicine, the Association of Academic Physiatrists and the American Association of Electrodiagnostic Medicine.

Dr. McDonald earned an AB in Human Biology from Stanford University, an MS in Rehabilitation Medicine from University of Washington and his MD from University of Washington School of Medicine.

Perry Shieh, MD, PhD, is Professor of Neurology at the David Geffen School of Medicine at UCLA. He received his MD and his PhD in Neuroscience from Johns Hopkins University in Baltimore, Maryland. He completed residency training in neurology at Stanford University Hospital and fellowship training in clinical neurophysiology/EMG at Brigham and Women’s Hospital. Dr. Shieh is a member of the American Academy of Neurology and a Fellow of the American Academy of Neuromuscular and Electrodiagnostic Medicine.

Dr. Shieh lectures both nationally and internationally on topics including chronic inflammatory demyelinating polyneuropathy (CIDP), treatments for genetic neuromuscular diseases, the diagnosis of neuromuscular disorders using next-generation sequencing and emerging therapies for Duchenne muscular dystrophy and spinal muscular atrophy. His research has been published in clinical journals such as Annals of Neurology, Neurology, Nature Genetics and JAMA. Dr. Shieh’s principal clinical interests include Duchene muscular dystrophy (DMD), spinal muscular atrophy, facioscapulohumeral muscular dystrophy (FSHD), myotonic dystrophy, inflammatory myopathy, myasthenia gravis, electromyography and muscle histopathology. He has served as an investigator in numerous clinical trials for neuromuscular conditions.